Sign in
4

Changes in Ownership

MAXCYTE, INC. Filed Acc 0001209191-23-040058

Director sold 15,000 shares at an average $4.44 ($66,603)

  • Director acquired 15,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Johnston John Joseph Director 2023-06-26 Option exercise 10b5-1 +6,817 $0.98 $6,701 127,400 D: show line 1 in the form
Johnston John Joseph Director 2023-06-26 Option exercise 10b5-1 +712 $1.64 $1,168 128,112 D: show line 2 in the form
Johnston John Joseph Director 2023-06-26 Sale 10b5-1 −7,529 $4.49 $33,805 120,583 D: show line 3 in the form
Johnston John Joseph Director 2023-06-27 Option exercise 10b5-1 +7,471 $1.64 $12,260 128,054 D: show line 4 in the form
Johnston John Joseph Director 2023-06-27 Sale 10b5-1 −7,471 $4.39 $32,798 120,583 D: show line 5 in the form
Open-market sales · 15,000 sh · avg $4.44 · $66,603

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Johnston John Joseph Director 2023-06-26 Option exercise · Stock Option (right to buy) 10b5-1 −6,817 0 D: show line 6 in the form
Johnston John Joseph Director 2023-06-26 Option exercise · Stock Option (right to buy) 10b5-1 −712 26,188 D: show line 7 in the form
Johnston John Joseph Director 2023-06-27 Option exercise · Stock Option (right to buy) 10b5-1 −7,471 18,717 D: show line 8 in the form
Loading xslF345X04/doc4.xml…